Bỏ qua để đến Nội dung
· Chất làm đầy da
SKU 11053 · GTIN 4046222005146

Radiesse (+) Lidocaine

Còn hàng
Dung tích
1 x 1,5 mL
Nhà sản xuất
Merz Aesthetics
Xuất xứ
Hợp chủng quốc Hoa Kỳ
Giá bán sỉ và lịch sử giá chỉ dành cho tài khoản đã xác minh
allpara cung cấp sản phẩm cho người hành nghề có giấy phép. Đăng nhập hoặc đăng ký tài khoản B2B để xem giá theo thời gian thực, các mức giá theo số lượng và lịch sử giá.

Radiesse (+) Lidocaine is a sterile, latex-free, non-pyrogenic, semi-solid cohesive injectable implant manufactured by Merz Aesthetics, developed for deep dermal and sub-dermal soft tissue augmentation. It suits supraperiosteal, sub-dermal and deep dermal placement with a 27G needle, and deep blunt-tip cannula injection for the jawline. It is 30% synthetic CaHA particles (25 to 45 microns) in a 70% gel carrier with 0.3% lidocaine hydrochloride; the carrier dissipates in vivo while the CaHA remains, for long-term but non-permanent augmentation. One 1.5 mL pre-filled syringe and two 27G thin-wall needles come sterile in a sealed foil pouch, for single treatment use.

Lợi ích chính của Radiesse (+) Lidocaine

  • Synthetic calcium hydroxylapatite implant with 0.3% lidocaine hydrochloride included for a short-term local anaesthetic effect during injection
  • 30% CaHA particles and 70% gel carrier by volume, with a particle size of 25 to 45 microns
  • The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the CaHA remains at the injection site
  • Indicated for the jawline and marionette lines in addition to nasolabial folds, cheeks and the dorsum of the hands
  • A lifetime of at least 12 months for cheek augmentation, the jawline and hand augmentation, as demonstrated minimums rather than expected end points
  • Well suited to supraperiosteal, sub-dermal and deep dermal placement; jawline placement by blunt-tip cannula has been clinically evaluated
  • Supplied sterile in a sealed foil pouch as one 1.5 mL syringe with two 27G thin-wall needles
  • CE marked under EU MDR 2017/745 via notified body 0123, supplied with a patient Implant Card
  • Manufactured by Merz Aesthetics in the USA
Thông tin chính
Thương hiệu RADIESSE
Nhà sản xuất Merz Aesthetics
Xuất xứ United States
Chứng nhận CE 0123
Thành phần Synthetic calcium hydroxylapatite (CaHA) particles, 25-45 microns, suspended in a gel carrier of sterile water for injection, glycerin, sodium carboxymethylcellulose and 0.3% lidocaine hydrochloride (w/v), buffered with sodium phosphate salts. By volume 30% CaHA particles and 70% gel carrier; by weight CaHA 55.6-56.5%, sterile water 35.4-36.2%, glycerin 6.3-6.5%, sodium carboxymethylcellulose 1.06-1.36%, phosphates 0.30-0.31% and lidocaine HCl monohydrate 0.22-0.23%. Non-animal-based and free from animal protein
Dung tích / Kích thước 1.5 ml
Đóng gói One pre-filled 1.5 mL syringe with a Terumo K-Pack II containing two 27G thin-wall injection needles, supplied sterile in a sealed foil pouch. Single person, single treatment use
Kích thước kim 27G thin-wall needle with a standard Luer fitting; two needles supplied in the pack
Loại sử dụng For professional use: qualified practitioners and clinics only
Độ sâu tiêm Deep dermal and sub-dermal soft tissue augmentation. Highly viscoelastic CaHA is well suited to supraperiosteal, sub-dermal and deep dermal placement. For the jawline, deep injection by blunt-tip cannula has been clinically evaluated
Liệu trình / Thời gian A lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6-7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points. Duration varies with the patient, the area treated, the volume placed and the injection technique

Chỉ định và sử dụng chuyên môn

Chỉ định chính

  • Treatment of nasolabial folds
  • Augmentation of the cheeks
  • Treatment of marionette lines
  • Treatment of the jawline
  • Hand augmentation to correct volume loss in the dorsum of the hands

Sử dụng chuyên môn

Radiesse (+) Lidocaine is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law. The product is supplied sterile and non-pyrogenic in a sealed foil pouch and is intended for single-person, single-treatment use only, for deep dermal and sub-dermal soft tissue augmentation. Because this presentation contains 0.3% lidocaine hydrochloride, practitioners must screen for known hypersensitivity to lidocaine or to anaesthetics of the amide type before use. Injection technique, plane and volume are determined by the treating practitioner on a per-patient basis. Introduction of the implant into the vasculature may lead to embolisation, occlusion of the vessels, ischaemia or infarction, so particular care is required when injecting soft tissue fillers. The product must not be re-sterilised, and must not be used if the foil pouch is compromised or the syringe damaged.

Vùng điều trị

  • Nasolabial folds
  • Cheeks
  • Marionette lines
  • Jawline
  • Dorsum of the hands
  • Not intended for the glabellar folds or the nose area, where a higher incidence of localised necrosis has been associated with injection

Đối tượng bệnh nhân

Suitable for adult patients assessed as appropriate by the treating practitioner. Radiesse (+) Lidocaine is contraindicated in the presence of acute or chronic inflammation or infection involving the area to be treated; in persons with severe allergies manifested by a history of anaphylaxis, or a history or presence of multiple severe allergies; in persons with known hypersensitivity to any of the components; in persons with known hypersensitivity to lidocaine or to anaesthetics of the amide type; in persons prone to developing inflammatory skin conditions or with a tendency to develop hypertrophic scars and keloids; in persons with bleeding disorders; in persons under 18 years; and during pregnancy and in breastfeeding females. It must not be implanted in the epidermis or used as a skin replacement, and is not intended for correction of the glabellar folds or the nose area. For hand augmentation, the safety of injection into the dorsum of the hand has not been studied in persons under 26 or over 79 years of age, volumes over 3 mL per hand in a treatment session have not been studied, and safety beyond two years in the hand has not been investigated in clinical trials.

Cơ chế hoạt động của Radiesse (+) Lidocaine ​

Radiesse (+) Lidocaine works through synthetic calcium hydroxylapatite microspheres, 25 to 45 microns in size, suspended in a gel carrier of sterile water, glycerin, sodium carboxymethylcellulose and 0.3% lidocaine hydrochloride. The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection, producing a long-term yet non-permanent restoration and augmentation. Highly viscoelastic CaHA is well suited to supraperiosteal, sub-dermal and deep dermal placement, where it delivers a considerable volumising effect. The lidocaine acts locally during administration to provide a short-term anaesthetic effect and does not alter this action.

Vì sao nên đặt hàng tại Allpara

Allpara cung cấp sản phẩm RADIESSE chính hãng, đã được xác minh, từ các nhà cung cấp được tuyển chọn, với khả năng truy xuất lô đầy đủ và hỗ trợ chuyên môn. Chúng tôi phục vụ các phòng khám và chuyên gia thẩm mỹ với sản phẩm đạt chứng nhận CE, giao hàng nhanh khắp EU từ kho tại EU và giá chuyên nghiệp cạnh tranh. Ưu tiên của chúng tôi là sự an toàn, hài lòng và kết quả của bệnh nhân của bạn, cùng dịch vụ hậu mãi tận tâm để bạn hoàn toàn yên tâm.

Câu hỏi thường gặp

How does Radiesse (+) Lidocaine differ from standard Radiesse?

Radiesse (+) Lidocaine contains 0.3% lidocaine hydrochloride in the gel carrier, which provides a short-term local anaesthetic effect during administration. The indications also differ: this presentation covers marionette lines and the jawline in addition to nasolabial folds, cheeks and the dorsum of the hands.

Which areas is Radiesse (+) Lidocaine indicated for?

It is indicated for the treatment of nasolabial folds, augmentation of the cheeks, treatment of marionette lines, treatment of the jawline, and hand augmentation to correct volume loss in the dorsum of the hands. It is not intended for the glabellar folds or the nose area.

How long does Radiesse (+) Lidocaine last?

It has a lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6 to 7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points.

Thêm sản phẩm từ Merz

Xem nhà sản xuất

BELOTERO mã hàng do ALLPARA lưu kho cho mục đích chuyên môn, nhập trực tiếp và có chứng nhận cho mỗi lô giao.

Xem BELOTERO sản phẩm

Lựa chọn thay thế cho phòng khám

Tất cả sản phẩm

Radiesse (+) Lidocaine

Còn hàng
Đạt dấu CE Đạt dấu CE Radiesse (+) Lidocaine
Giá chỉ dành cho tài khoản đã xác minh
Đăng nhập hoặc đăng ký tài khoản B2B để xem giá của bạn.
Đăng ký tài khoản B2B

Radiesse (+) Lidocaine is a sterile, latex-free, non-pyrogenic, semi-solid cohesive injectable implant manufactured by Merz Aesthetics, developed for deep dermal and sub-dermal soft tissue augmentation. It suits supraperiosteal, sub-dermal and deep dermal placement with a 27G needle, and deep blunt-tip cannula injection for the jawline. It is 30% synthetic CaHA particles (25 to 45 microns) in a 70% gel carrier with 0.3% lidocaine hydrochloride; the carrier dissipates in vivo while the CaHA remains, for long-term but non-permanent augmentation. One 1.5 mL pre-filled syringe and two 27G thin-wall needles come sterile in a sealed foil pouch, for single treatment use.

Lợi ích chính của Radiesse (+) Lidocaine

  • Synthetic calcium hydroxylapatite implant with 0.3% lidocaine hydrochloride included for a short-term local anaesthetic effect during injection
  • 30% CaHA particles and 70% gel carrier by volume, with a particle size of 25 to 45 microns
  • The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the CaHA remains at the injection site
  • Indicated for the jawline and marionette lines in addition to nasolabial folds, cheeks and the dorsum of the hands
  • A lifetime of at least 12 months for cheek augmentation, the jawline and hand augmentation, as demonstrated minimums rather than expected end points
  • Well suited to supraperiosteal, sub-dermal and deep dermal placement; jawline placement by blunt-tip cannula has been clinically evaluated
  • Supplied sterile in a sealed foil pouch as one 1.5 mL syringe with two 27G thin-wall needles
  • CE marked under EU MDR 2017/745 via notified body 0123, supplied with a patient Implant Card
  • Manufactured by Merz Aesthetics in the USA
Thông tin chính
Thương hiệu RADIESSE
Nhà sản xuất Merz Aesthetics
Xuất xứ United States
Chứng nhận CE 0123
Thành phần Synthetic calcium hydroxylapatite (CaHA) particles, 25-45 microns, suspended in a gel carrier of sterile water for injection, glycerin, sodium carboxymethylcellulose and 0.3% lidocaine hydrochloride (w/v), buffered with sodium phosphate salts. By volume 30% CaHA particles and 70% gel carrier; by weight CaHA 55.6-56.5%, sterile water 35.4-36.2%, glycerin 6.3-6.5%, sodium carboxymethylcellulose 1.06-1.36%, phosphates 0.30-0.31% and lidocaine HCl monohydrate 0.22-0.23%. Non-animal-based and free from animal protein
Dung tích / Kích thước 1.5 ml
Đóng gói One pre-filled 1.5 mL syringe with a Terumo K-Pack II containing two 27G thin-wall injection needles, supplied sterile in a sealed foil pouch. Single person, single treatment use
Kích thước kim 27G thin-wall needle with a standard Luer fitting; two needles supplied in the pack
Loại sử dụng For professional use: qualified practitioners and clinics only
Độ sâu tiêm Deep dermal and sub-dermal soft tissue augmentation. Highly viscoelastic CaHA is well suited to supraperiosteal, sub-dermal and deep dermal placement. For the jawline, deep injection by blunt-tip cannula has been clinically evaluated
Liệu trình / Thời gian A lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6-7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points. Duration varies with the patient, the area treated, the volume placed and the injection technique

Chỉ định và sử dụng chuyên môn

Chỉ định chính

  • Treatment of nasolabial folds
  • Augmentation of the cheeks
  • Treatment of marionette lines
  • Treatment of the jawline
  • Hand augmentation to correct volume loss in the dorsum of the hands

Sử dụng chuyên môn

Radiesse (+) Lidocaine is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law. The product is supplied sterile and non-pyrogenic in a sealed foil pouch and is intended for single-person, single-treatment use only, for deep dermal and sub-dermal soft tissue augmentation. Because this presentation contains 0.3% lidocaine hydrochloride, practitioners must screen for known hypersensitivity to lidocaine or to anaesthetics of the amide type before use. Injection technique, plane and volume are determined by the treating practitioner on a per-patient basis. Introduction of the implant into the vasculature may lead to embolisation, occlusion of the vessels, ischaemia or infarction, so particular care is required when injecting soft tissue fillers. The product must not be re-sterilised, and must not be used if the foil pouch is compromised or the syringe damaged.

Vùng điều trị

  • Nasolabial folds
  • Cheeks
  • Marionette lines
  • Jawline
  • Dorsum of the hands
  • Not intended for the glabellar folds or the nose area, where a higher incidence of localised necrosis has been associated with injection

Đối tượng bệnh nhân

Suitable for adult patients assessed as appropriate by the treating practitioner. Radiesse (+) Lidocaine is contraindicated in the presence of acute or chronic inflammation or infection involving the area to be treated; in persons with severe allergies manifested by a history of anaphylaxis, or a history or presence of multiple severe allergies; in persons with known hypersensitivity to any of the components; in persons with known hypersensitivity to lidocaine or to anaesthetics of the amide type; in persons prone to developing inflammatory skin conditions or with a tendency to develop hypertrophic scars and keloids; in persons with bleeding disorders; in persons under 18 years; and during pregnancy and in breastfeeding females. It must not be implanted in the epidermis or used as a skin replacement, and is not intended for correction of the glabellar folds or the nose area. For hand augmentation, the safety of injection into the dorsum of the hand has not been studied in persons under 26 or over 79 years of age, volumes over 3 mL per hand in a treatment session have not been studied, and safety beyond two years in the hand has not been investigated in clinical trials.

Cơ chế hoạt động của Radiesse (+) Lidocaine ​

Radiesse (+) Lidocaine works through synthetic calcium hydroxylapatite microspheres, 25 to 45 microns in size, suspended in a gel carrier of sterile water, glycerin, sodium carboxymethylcellulose and 0.3% lidocaine hydrochloride. The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection, producing a long-term yet non-permanent restoration and augmentation. Highly viscoelastic CaHA is well suited to supraperiosteal, sub-dermal and deep dermal placement, where it delivers a considerable volumising effect. The lidocaine acts locally during administration to provide a short-term anaesthetic effect and does not alter this action.

Vì sao nên đặt hàng tại Allpara

Allpara cung cấp sản phẩm RADIESSE chính hãng, đã được xác minh, với khả năng truy xuất lô đầy đủ, hàng đạt chứng nhận CE, giao hàng nhanh khắp EU và hỗ trợ hậu mãi chuyên nghiệp.

Câu hỏi thường gặp

How does Radiesse (+) Lidocaine differ from standard Radiesse?

Radiesse (+) Lidocaine contains 0.3% lidocaine hydrochloride in the gel carrier, which provides a short-term local anaesthetic effect during administration. The indications also differ: this presentation covers marionette lines and the jawline in addition to nasolabial folds, cheeks and the dorsum of the hands.

Which areas is Radiesse (+) Lidocaine indicated for?

It is indicated for the treatment of nasolabial folds, augmentation of the cheeks, treatment of marionette lines, treatment of the jawline, and hand augmentation to correct volume loss in the dorsum of the hands. It is not intended for the glabellar folds or the nose area.

How long does Radiesse (+) Lidocaine last?

It has a lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6 to 7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points.

Thêm sản phẩm từ Merz

Xem nhà sản xuất →
* Sản phẩm dùng cho chuyên môn. Bao bì có thể khác nhau tùy theo lô hoặc thị trường. Vui lòng tham khảo hướng dẫn sử dụng kèm theo để biết đầy đủ cách dùng và chống chỉ định.